# Legionella Testing Market

> Legionella Testing Market Research Report: Size, Share, Trend Analysis By Test Type (Culture Tests, Polymerase Chain Reaction, Antigen Detection Tests, Nucleic Acid Amplification Tests), By Technology (Traditional Methods, Molecular Methods, Immunological Methods), By Sample Type (Water Samples, Environmental Samples, Clinical Samples), By End Users (Hospitals, Laboratories, Public Health Organizations, Research Institutions) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.34%
- **2024:** $ 0.83 Billion
- **2025:** $ 0.87 Billion
- **2035:** $ 1.47 Billion
- **Key Players:** Thermo Fisher Scientific(US), Merck KGaA (DE), Hach Company (US), Eurofins Scientific (LU), SGS SA (CH), Bureau Veritas (FR), Intertek Group plc (GB), Pace Analytical Services, LLC (US), ALS Limited (AU)

**Report ID:** MRFR/HC/31203-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/legionella-testing-market-33014

---

## Market Summary

## **Legionella Testing Market Overview**

As per MRFR analysis, the Legionella Testing Market Size was estimated at 0.83 (USD Billion) in 2024. The Legionella Testing Market Industry is expected to grow from 0.87 (USD Billion) in 2025 to 1.40 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 5.34% during the forecast period (2025 - 2034).

### **Key Legionella Testing Market Trends Highlighted**

The Legionella Testing Market is influenced by several key market drivers that shape its growth and evolution. Increasing awareness about waterborne diseases, particularly in industrial and residential settings, highlights the necessity for reliable testing methods. Stricter regulatory standards for water quality and safety further propel the demand for Legionella testing, as organizations aim to prevent outbreaks and ensure compliance in environments such as healthcare facilities, hotels, and recreational water sources. The rising incidence of pneumonia cases attributed to Legionella also underscores the critical need for effective monitoring and testing practices.As the market evolves, numerous opportunities emerge for stakeholders to explore.

Advancements in testing technology present a unique chance for companies to innovate and offer solutions that are faster, more accurate, and cost-effective.

There is a growing demand for point-of-use testing kits that provide real-time results, which can significantly enhance response measures in potentially contaminated environments. Collaboration with public health organizations can also open avenues for spreading awareness and education about the risks of Legionella, leading to increased market penetration. Recent trends indicate a shift towards more integrated testing approaches, combining traditional methods with new technologies such as molecular testing and automated systems that streamline the testing process.

Additionally, the pandemic has heightened the focus on environmental monitoring, making indoor air and water safety paramount. This trend is orchestrating a surge in demand for comprehensive testing solutions as organizations prioritize the health of occupants and compliance with safety regulations. As the market navigates these dynamics, understanding consumer needs and regulatory landscapes will be essential for capitalizing on growth opportunities.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Legionella Testing Market Drivers**

### **Rising Awareness of Legionella Risks and Regulations**

The increasing awareness regarding the health impacts of Legionella bacteria is a significant driver for the Legionella Testing Market Industry. Growing public health concerns propelled by various outbreaks of Legionnaires' disease have encouraged individuals, organizations, and regulatory bodies to recognize the importance of regular testing and monitoring. Consequently, governmental agencies are implementing stricter regulations and guidelines to ensure water safety in public and private facilities.These regulations necessitate routine monitoring of water systems in hospitals, hotels, and industrial facilities, which in turn boosts demand for robust Legionella testing solutions.

Moreover, the public's understanding of how Legionella bacteria can proliferate within building water systems, air-conditioning units, and decorative fountains is prompting more stakeholders to adopt preventive measures.

As a result, the rising awareness and regulatory push are expected to propel growth in the Legionella Testing Market, fostering an environment where testing becomes a routine practice rather than an exception.This awareness is critical for industries involved in water management, healthcare, and hospitality, which consistently strive to mitigate risks associated with waterborne pathogens. Overall, the combined effect of increased public knowledge, reinforced guidelines, and proactive testing measures will significantly drive demand within this market.

### **Technological Advancements in Testing Methods**

Technological advancements play a pivotal role in driving growth within the Legionella Testing Market Industry. The continuous development of sophisticated testing methods, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), has enhanced the accuracy, sensitivity, and speed of Legionella detection. These innovations facilitate quicker results, enabling immediate action to be taken against potential contamination.

Advanced methodologies open up new possibilities for testing in various environments, promoting a proactive approach towards water safety management.As laboratories and testing facilities adopt these new technologies, the demand for reliable and rapid Legionella testing solutions is expected to rise, ensuring the safety of public and private water systems.

### **Growth of End-User Industries**

The expanding end-user industries, including healthcare, hospitality, and public infrastructure, significantly influence the Legionella Testing Market Industry. With the growing number of hospitals, hotels, and commercial buildings investing in improved water management systems, the demand for Legionella testing is set to increase. The healthcare sector particularly emphasizes stringent water safety protocols to safeguard patients from potential Legionnaires' disease outbreaks.Similarly, the hospitality industry recognizes the importance of maintaining high water quality standards to protect guests. As urban development continues and the need for reliable water management systems escalates, industries are more inclined to adopt Legionella testing services.

This growth in end-user industries fosters a favorable environment for the Legionella testing market, propelling its development in the coming years.

## **Legionella Testing Market Segment Insights**

### **Legionella Testing Market Test Type Insights  **

In 2023, the Legionella Testing Market was valued at 0.75 USD Billion, showcasing a steady demand for effective testing methodologies across various segments, particularly in the Test Type category. The Culture Tests held a dominant position within this market segment, valued at 0.3 USD Billion, and expected to rise to 0.5 USD Billion by 2032. This methodology is significant as it allows for the identification and quantification of Legionella bacteria in water samples, which is crucial for ensuring water quality and public health safety.

Following Culture Tests, the Polymerase Chain Reaction (PCR) testing segment is also noteworthy, valued at 0.2 USD Billion in 2023 and projected to grow to 0.35 USD Billion by 2032.PCR is vital for its rapid, accurate, and sensitive detection capabilities, making it an essential tool in clinical diagnostics and environmental monitoring. The Antigen Detection Tests segment, valued at 0.15 USD Billion in 2023, is also important, forecasted to increase to 0.25 USD Billion by 2032. This method is valued for its quick turnaround times, providing timely results essential in outbreak situations.

Lastly, the Nucleic Acid Amplification Tests segment accounted for 0.1 USD Billion in 2023 and is expected to reflect growth to 0.2 USD Billion by 2032.While this segment currently holds the least value compared to the others, its relevance lies in its ability to precisely detect genetic material from Legionella, making it a promising area for future developments and innovations. The overall landscape of the Legionella Testing Market shows substantial possibilities for growth, driven by increasing awareness of waterborne diseases, regulatory requirements for water testing, and advancements in testing technologies.

As awareness grows regarding the importance of Legionella prevention in public health, the market is expected to flourish, providing opportunities across varying methodologies and encouraging advancements in testing efficiencies and accuracies.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Legionella Testing Market Technology Insights  **

The Legionella Testing Market reached a valuation of 0.75 billion USD in 2023 and is projected to grow significantly by 2032. The market growth is driven by the rising demand for effective testing methodologies to ensure public safety from Legionella outbreaks. Within this market, technology plays a crucial role, particularly in Traditional Methods, Molecular Methods, and Immunological Methods.

Traditional Methods remain essential for their established protocols and reliability in testing, while Molecular Methods offer greater sensitivity and faster results, becoming increasingly adopted in clinical and environmental testing.Immunological Methods present a significant avenue as they often allow rapid detection of Legionella species, aligning with the growing urgency for quick response in public health scenarios. Collectively, these testing technologies cater to diverse needs, showcasing the Legionella Testing Market's segmentation dynamics while addressing the escalating concern for waterborne pathogens and the regulatory pressures influencing market trends.

With rising awareness and technological advancements, the Legionella Testing Market statistics reveal a promising outlook for the various methodologies employed in detecting Legionella.

### **Legionella Testing Market Sample Type Insights  **

The Legionella Testing Market is witnessing substantial growth, with a market valuation of 0.75 billion USD in 2023. This growth is underpinned by the importance of various sample types, particularly Water Samples, Environmental Samples, and Clinical Samples. Water Samples hold a significant share in testing, driven by the frequent testing in various sectors, including residential, commercial, and industrial, to combat waterborne diseases. Environmental Samples are also vital, as they assess potential Legionella contamination in natural and engineered water systems.Clinical Samples facilitate the diagnosis of Legionnaires' disease, ensuring timely treatment.

The combined emphasis on these sample types showcases a robust market structure, where the persistent focus on public health is propelling the demand for effective Legionella testing solutions. The trend towards stringent regulations and standards for water quality further enhances the relevance of these samples within the Legionella Testing Market. As the market evolves, opportunities lie in technological advancements that improve the speed and accuracy of testing methodologies across these critical sample types.

### **Legionella Testing Market End User Insights  **

The Legionella Testing Market is valued at 0.75 billion USD in 2023 and is expected to exhibit notable growth over the coming years. The market segmentation highlights a diverse range of End Users, including Hospitals, Laboratories, Public Health Organizations, and Research Institutions. Hospitals play a crucial role in the detection and management of Legionella due to their responsibility for patient care and safety. Similarly, Laboratories are integral as they are primary facilities for conducting tests, thus holding a significant market share.Public Health Organizations contribute with their objective of managing community health and preventing outbreaks, directly impacting testing demand.

Research Institutions also bolster the market by advancing studies related to Legionella pathogen detection and control methodologies. Together, these End Users underscore the importance of the Legionella Testing Market revenue, driven by rising awareness of healthcare safety and increasing regulatory requirements for water quality testing, thus spurring overall market growth.

### **Legionella Testing Market Regional Insights  **

The Legionella Testing Market revenue is expected to showcase a steady growth trend across its regional segments, with North America holding the majority share. In 2023, North America was valued at 0.3 USD Billion, increasing to 0.48 USD Billion by 2032, showcasing its significant demand for effective Legionella testing solutions. Europe follows suit, valued at 0.2 USD Billion in 2023 and anticipated to rise to 0.32 USD Billion by 2032, indicating its notable focus on water safety regulations.

The APAC region stands at 0.15 USD Billion in 2023 and is set to grow to 0.24 USD Billion, driven by increasing urbanization and industrial development necessitating better testing measures.South America and MEA both begin at 0.05 USD Billion in 2023, with projections of reaching 0.08 USD Billion by 2032. Although these regions exhibit smaller market sizes, the growing awareness regarding waterborne pathogens presents opportunities for market expansion. Collectively, these figures highlight the Legionella Testing Market data across regions, emphasizing the varying degrees of market penetration, consumer awareness, and regulatory factors influencing market growth.

Moreover, the statistics reflect both challenges and opportunities within these regions, notably the industrial development in APAC and the stringent regulations in Europe, which drive the need for advanced testing solutions.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Legionella Testing Market Key Players and Competitive Insights**

The Legionella Testing Market is characterized by a diverse and competitive landscape, driven by the increasing need for testing solutions due to rising health concerns associated with Legionella bacteria. As regulatory standards tighten and awareness about Legionnaires' disease grows, several key players are actively engaged in developing advanced testing methodologies, enhancing product offerings, and expanding their geographical footprint. Innovation, particularly in rapid testing technologies and accurate detection methods, plays a pivotal role in shaping the competition. Companies in this market are also focusing on strategic collaborations and partnerships, influencing their market positioning and visibility.

Overall, the competitive insights within this market highlight a race towards efficiency, accuracy, and reliability in Legionella detection, with a commitment to improving public health safety.GE Healthcare is recognized as a significant player within the Legionella Testing Market, leveraging its extensive experience in healthcare technology to offer advanced diagnostic solutions. 

The company has established a strong presence in the market by providing innovative testing platforms that ensure rapid and precise detection of Legionella bacteria. GE Healthcare's strengths lie in its commitment to research and development, continuous improvement of its testing methods, and integration of cutting-edge technology into its products. Their robust distribution networks and established customer relationships further enhance their competitive edge. 

The company's focus on quality and compliance with health and safety regulations supports its credibility and trustworthiness in the market, positioning it favorably in scenarios demanding comprehensive testing and analysis for Legionella.EnviroSuite has carved out a notable niche within the Legionella Testing Market by focusing on environmental monitoring and management solutions. Its strengths lie in the company's advanced analytical tools and technologies that provide reliable data for environmental health assessments, including Legionella surveillance. EnviroSuite employs innovative strategies, utilizing real-time data analytics to enhance the effectiveness of water quality monitoring and to deliver actionable insights for risk management.

Moreover, the company's commitment to customer-centric solutions and adaptability to evolving regulatory requirements enhances its appeal in the market. By fostering partnerships with various stakeholders, EnviroSuite fortifies its position as an essential contributor to Legionella testing initiatives, aiming to improve public health outcomes through proactive environmental management solutions.

### **Key Companies in the Legionella Testing Market Include**

- GE Healthcare
- EnviroSuite
- Randox Laboratories
- Sigma-Aldrich
- **[Merck KGaA](https://www.merckmillipore.com/IN/en/products/industrial-microbiology/pathogen-and-spoilage-testing/pathogen-detection/pathogen-detection-by-organism/legionella/nBib.qB.8XoAAAFAAP1kiQpx,nav)**
- BioRad Laboratories
- Neogen Corporation
- Thermo Fisher Scientific
- Adpath Laboratories
- Hach
- ASCE
- MilliporeSigma
- Cleveland Biolabs
- Waters Corporation

## Legionella Testing Industry Developments

- **Q2 2024: IDEXX Launches Legiolert Test for Rapid Detection of Legionella pneumophila in Water** IDEXX announced the launch of its Legiolert test, designed to rapidly detect Legionella pneumophila in water samples, aiming to improve public health safety and compliance with water testing regulations.
- **Q1 2024: QuidelOrtho Corporation Receives CE Mark for Sofia Legionella FIA Test** QuidelOrtho Corporation received CE Mark approval for its Sofia Legionella FIA test, enabling the company to market the product in the European Union for rapid detection of Legionella antigens in clinical samples.
- **Q2 2024: Thermo Fisher Scientific Expands Legionella Testing Portfolio with New PCR Assay** Thermo Fisher Scientific announced the expansion of its Legionella testing portfolio by launching a new PCR assay, designed to provide faster and more accurate detection of Legionella species in water systems.
- **Q2 2024: Bio-Rad Laboratories Announces Partnership with European Water Utility for Legionella Monitoring** Bio-Rad Laboratories entered into a partnership with a major European water utility to supply Legionella testing kits and support ongoing monitoring programs to prevent outbreaks in municipal water systems.
- **Q1 2024: Qiagen Launches New Automated Legionella Testing Platform** Qiagen launched a new automated platform for Legionella testing, aiming to streamline laboratory workflows and improve the speed and reliability of Legionella detection in environmental samples.
- **Q2 2024: Eiken Chemical Co., Ltd. Announces Expansion of Legionella Test Production Facility in Japan** Eiken Chemical Co., Ltd. announced the opening of an expanded production facility in Japan dedicated to manufacturing Legionella test kits, responding to increased demand for water safety testing.
- **Q1 2025: Pro-Lab Diagnostics Receives UK Regulatory Approval for New Legionella Rapid Test** Pro-Lab Diagnostics received regulatory approval in the UK for its new rapid Legionella test, allowing the company to market the product to healthcare and environmental testing laboratories.
- **Q2 2025: Abbott Laboratories Launches Next-Generation Legionella Detection System** Abbott Laboratories launched a next-generation Legionella detection system, featuring enhanced sensitivity and faster turnaround times for water testing in commercial and healthcare settings.
- **Q1 2025: QuidelOrtho Corporation Announces Strategic Partnership with US Hospital Network for Legionella Surveillance** QuidelOrtho Corporation announced a strategic partnership with a large US hospital network to implement Legionella surveillance programs using its diagnostic products.
- **Q2 2024: Thermo Fisher Scientific Acquires Small Diagnostics Firm Specializing in Legionella Testing** Thermo Fisher Scientific completed the acquisition of a diagnostics firm specializing in Legionella testing, aiming to strengthen its position in the waterborne pathogen detection market.
- **Q1 2024: IDEXX Receives US EPA Approval for Legiolert Test Method** IDEXX received approval from the US Environmental Protection Agency (EPA) for its Legiolert test method, allowing its use in official water quality monitoring programs.
- **Q2 2025: Bio-Rad Laboratories Announces $20 Million Investment to Expand Legionella R&D** Bio-Rad Laboratories announced a $20 million investment to expand research and development efforts focused on new Legionella detection technologies and products.

## **Legionella Testing Market Segmentation Insight**

### **Legionella Testing Market Test Type Outlook**

- Culture Tests
- Polymerase Chain Reaction
- Antigen Detection Tests
- Nucleic Acid Amplification Tests

### **Legionella Testing Market Technology Outlook**

- Traditional Methods
- Molecular Methods
- Immunological Method

### **Legionella Testing Market Sample Type Outlook**

- Water Samples
- Environmental Samples
- Clinical Samples

### **Legionella Testing Market End User Outlook**

- Hospitals
- Laboratories
- Public Health Organizations
- Research Institutions

### **Legionella Testing Market Regional Outlook**

- North America
- Europe
- South America
- Asia-Pacific
- Middle East and Africa

## Market Drivers

### Rising Public Health Concerns

Public health concerns regarding waterborne diseases are driving the Legionella Testing Market. With increasing awareness of the health risks associated with Legionella bacteria, there is a growing emphasis on preventive measures in both residential and commercial settings. Reports indicate that Legionnaires disease cases have been on the rise, prompting health authorities to advocate for regular testing of water systems. This heightened awareness is likely to lead to increased investments in Legionella testing services, as organizations aim to safeguard public health and comply with emerging health guidelines. Consequently, the market is poised for growth as stakeholders recognize the importance of proactive testing in mitigating health risks.

### Increased Regulatory Compliance

The Legionella Testing Market is experiencing heightened regulatory compliance requirements across various sectors, particularly in healthcare and hospitality. Governments and health organizations are implementing stringent guidelines to ensure water safety and prevent outbreaks of Legionnaires disease. For instance, regulations may mandate routine testing of water systems in large buildings, which drives demand for Legionella testing services. The market is projected to grow as organizations seek to comply with these regulations, with estimates suggesting a compound annual growth rate of around 8% over the next few years. This regulatory landscape compels facilities to invest in reliable testing solutions, thereby expanding the Legionella Testing Market.

### Technological Innovations in Testing

Technological advancements are significantly influencing the Legionella Testing Market. Innovations such as rapid testing methods and automated sampling systems are enhancing the efficiency and accuracy of Legionella detection. For example, the introduction of PCR-based testing techniques allows for quicker results, which is crucial for timely interventions. The market is likely to see an increase in the adoption of these advanced technologies, as they not only improve testing turnaround times but also reduce labor costs associated with traditional methods. As organizations prioritize effective water management strategies, the demand for innovative testing solutions is expected to rise, further propelling the Legionella Testing Market.

### Increased Investment in Infrastructure

Increased investment in infrastructure, particularly in aging water systems, is significantly impacting the Legionella Testing Market. Many regions are facing challenges related to outdated plumbing and water distribution systems, which can harbor Legionella bacteria. As governments and private entities allocate funds for infrastructure upgrades, there is a growing need for effective testing solutions to ensure water safety. This investment trend is likely to drive demand for Legionella testing services, as stakeholders seek to mitigate risks associated with legacy systems. The market may witness substantial growth as infrastructure improvements necessitate enhanced testing protocols to protect public health and comply with regulatory standards.

### Expansion of Water Management Practices

The expansion of water management practices across various industries is a key driver for the Legionella Testing Market. As organizations increasingly recognize the importance of maintaining water quality, there is a corresponding rise in the implementation of comprehensive water management programs. These programs often include regular Legionella testing as a critical component to ensure safe water systems. Industries such as healthcare, hospitality, and manufacturing are particularly focused on enhancing their water management protocols, which is likely to result in a surge in demand for Legionella testing services. This trend indicates a robust growth trajectory for the Legionella Testing Market as more entities prioritize water safety.

## Future Outlook

The Legionella Testing Market is projected to grow at a 5.34% CAGR from 2025 to 2035, driven by increasing regulatory requirements and heightened public health awareness.

**New opportunities:**

- Development of rapid testing kits for on-site analysis Expansion of digital platforms for remote testing services Partnerships with healthcare facilities for integrated testing solutions

By 2035, the Legionella Testing Market is expected to be robust, driven by innovation and strategic partnerships.

## Segment Insights

### By Test Type: Culture Tests (Largest) vs. Polymerase Chain Reaction (Fastest-Growing)

The Legionella Testing Market reveals a diverse distribution of test types across its segments, with Culture Tests holding the largest market share. These traditional methods benefit from utilization in laboratories where accuracy and reliability are paramount. On the other hand, Polymerase Chain Reaction (PCR) tests are rapidly gaining traction, indicating a shift towards more advanced molecular testing techniques. The growing preference for rapid and sensitive detection methods is reshaping market dynamics.

Testing Techniques: Culture Tests (Dominant) vs. Nucleic Acid Amplification Tests (Emerging)

Culture Tests remain the dominant players in the Legionella Testing Market, known for their high specificity and ability to grow the Legionella bacteria for accurate identification. They are particularly favored in clinical settings due to their time-tested efficacy and regulatory approval. Conversely, Nucleic Acid Amplification Tests (NAATs) are emerging as the next frontier, leveraging cutting-edge technology to provide faster results with higher sensitivity. As regulatory approvals increase and healthcare facilities seek efficient testing solutions, NAATs are expected to carve out a significant niche, indicating a transition towards more rapid diagnostic methods.

### By Technology: Traditional Methods (Largest) vs. Molecular Methods (Fastest-Growing)

In the Legionella Testing Market, the share of technology segments is diversifying, with Traditional Methods occupying the largest market share. These methods, including culture-based techniques, remain preferred due to their established reliability among laboratories. The stability of these techniques underpins their dominance, appealing to sectors that value proven methodologies in water quality testing. Conversely, Molecular Methods are rapidly emerging as the fastest-growing segment due to their superior capability for rapid detection and specificity. The increasing demand for faster testing results in various environments, including hospitals and public water systems, drives this growth. The adoption of advanced techniques highlights a shift in market preferences towards efficiency, indicating a promising trajectory for future development in Legionella testing protocols.

Technology: Traditional Methods (Dominant) vs. Molecular Methods (Emerging)

Traditional Methods, such as culture and biochemical assays, deliver reliable results with a longer history of use in the testing of Legionella. These techniques require time and specific conditions to cultivate the organism, which while time-consuming, assures thorough accuracy in detection. On the other hand, Molecular Methods leverage PCR (Polymerase Chain Reaction) and other nucleic acid amplification technologies to provide rapid and sensitive detection of Legionella species. This transition showcases a significant trend towards embracing faster and more efficient approaches in testing, with Molecular Methods appealing to sectors needing quick analysis like the healthcare and industry, positioning them as a key player in the evolving landscape of Legionella testing.

### By Sample Type: Water Samples (Largest) vs. Environmental Samples (Fastest-Growing)

In the Legionella Testing Market, the sample type segment is prominently led by water samples, which account for the largest share due to their pivotal role in public health monitoring. Following water samples, environmental samples have emerged as the fastest-growing category, reflecting an increasing emphasis on comprehensive environmental assessments to prevent Legionella outbreaks. Clinical samples, while critical, occupy a smaller portion of the market, focusing mainly on disease diagnosis and management.

Water Samples (Dominant) vs. Environmental Samples (Emerging)

Water samples hold a dominant position in the Legionella Testing Market, primarily because of the high volume of testing required in water supply systems and recreational water bodies. Their importance is underscored by regulatory mandates and public health initiatives targeting Legionella prevention. On the other hand, environmental samples are gaining traction as emerging players in the market, driven by a growing awareness of the health risks associated with Legionella in diverse environments, such as cooling towers and industrial systems. This shift reflects an evolving landscape in legionella testing, driven by both regulatory changes and a broader understanding of environmental health.

### By End User: Hospitals (Largest) vs. Laboratories (Fastest-Growing)

In the Legionella Testing Market, hospitals command the largest share as they prioritize preventative measures against outbreaks in healthcare settings. They are required to maintain strict compliance with safety regulations, making reliable testing essential. Laboratories play a crucial role as well, contributing significantly to the overall market due to their extensive testing capabilities and partnerships with healthcare institutions. Their demand continues to rise as the importance of accurate and rapid testing becomes more recognized in managing public health risks.

Laboratories: Fastest-Growing vs. Public Health Organizations: Dominant

Laboratories represent the fastest-growing segment within the Legionella Testing Market as they expand their technological capabilities and service offerings to meet increasing demand. Their agility in adopting new testing methods allows them to serve diverse clientele, including hospitals and public health organizations. On the other hand, public health organizations remain a dominant force, focusing on regulatory compliance and public safety through effective monitoring and response strategies. This segment benefits from increased government funding and public awareness initiatives to enhance testing capacity in response to Legionella risks.

## Regional Market Share Analysis

### North America : Regulatory Leader in Testing

North America is the largest market for Legionella testing, accounting for approximately 45% of the global share. The region's growth is driven by stringent regulations regarding water quality and public health, particularly in the U.S. and Canada. Increased awareness of Legionnaires' disease and its health implications has led to a surge in demand for testing services. Regulatory bodies like the EPA have implemented guidelines that further catalyze market growth. The U.S. is the leading country in this market, with significant contributions from key players such as Thermo Fisher Scientific and Hach Company. Canada follows as the second-largest market, focusing on compliance with health regulations. The competitive landscape is characterized by a mix of established legionella water testing companies and emerging players, all striving to innovate and meet the growing demand for reliable testing solutions.

### Europe : Emerging Regulatory Frameworks

Europe is witnessing a growing demand for Legionella testing, holding approximately 30% of the global market share. The region's growth is fueled by increasing regulatory frameworks aimed at ensuring water safety and public health. Countries like Germany and France are at the forefront, implementing stringent testing protocols to combat Legionnaires' disease outbreaks. The European Union's directives on water quality are significant catalysts for market expansion. Germany leads the European market, followed closely by France and the UK. The competitive landscape features major players like Merck KGaA and Eurofins Scientific, who are investing in advanced testing technologies. The presence of these key players enhances the market's robustness, as they strive to meet the evolving regulatory requirements and consumer demands for effective testing solutions.

### Asia-Pacific : Rapid Growth in Testing Services

Asia-Pacific is rapidly emerging as a significant player in the Legionella testing market, accounting for about 20% of the global share. The region's growth is driven by increasing industrialization, urbanization, and rising awareness of waterborne diseases. Countries like Australia and Japan are leading the charge, with regulatory bodies emphasizing the importance of water quality testing to prevent outbreaks of Legionnaires' disease. Australia is the largest market in the region, with Japan following closely. The competitive landscape is evolving, with both local and international players like ALS Limited and SGS SA expanding their presence. The demand for innovative testing solutions is on the rise, as stakeholders seek to comply with emerging regulations and ensure public health safety in rapidly urbanizing areas.

### Middle East and Africa : Growing Awareness and Regulation

The Middle East and Africa region is gradually recognizing the importance of Legionella testing, holding about 5% of the global market share. The growth is primarily driven by increasing awareness of water quality issues and the health risks associated with Legionnaires' disease. Countries like South Africa and the UAE are beginning to implement regulations that mandate testing in public facilities, which is expected to boost market demand significantly. South Africa is currently the leading market in this region, with the UAE showing promising growth potential. The competitive landscape is still developing, with a mix of local and international players entering the market. Legionella water testing companies are focusing on establishing partnerships and enhancing their service offerings to meet the growing regulatory requirements and consumer awareness regarding water safety.

## Competitive Benchmarking

The Legionella Testing Market is characterized by a dynamic competitive landscape, driven by increasing regulatory scrutiny and heightened awareness of public health. Key players are actively engaging in strategies that emphasize innovation, regional expansion, and partnerships to enhance their market positioning. Companies such as Thermo Fisher Scientific (US), Merck KGaA (DE), and Hach Company (US) are at the forefront, leveraging their technological capabilities to develop advanced testing solutions. This collective focus on innovation and strategic collaborations is shaping a competitive environment that is increasingly responsive to emerging health concerns and regulatory requirements. In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance operational efficiency and reduce lead times. The market appears moderately fragmented, with several key players exerting influence over specific regions. This fragmentation allows for niche players to thrive, while larger companies consolidate their positions through strategic acquisitions and partnerships. The interplay between these tactics and the competitive structure fosters a landscape where agility and responsiveness are paramount. In August 2025, Thermo Fisher Scientific (US), a key legionella testing company, announced the launch of a new rapid testing kit designed for Legionella detection in water systems. This innovation is significant as it addresses the urgent need for timely testing solutions in various industries, including healthcare and hospitality. By enhancing the speed and accuracy of testing, Thermo Fisher aims to solidify its market leadership and respond effectively to growing regulatory demands. In July 2025, Merck KGaA (DE) expanded its portfolio by acquiring a small biotech firm specializing in environmental testing technologies. This strategic move is indicative of Merck's commitment to enhancing its capabilities in the Legionella testing domain. The acquisition not only broadens its product offerings but also positions the legionella testing company to leverage cutting-edge technologies that could redefine testing methodologies in the future. In September 2025, Hach Company (US) entered into a partnership with a leading water management firm to integrate its testing solutions into smart water management systems. This collaboration is pivotal as it aligns with the growing trend of digitalization in water quality monitoring. By embedding its testing technologies within smart systems, Hach is likely to enhance its market reach and provide comprehensive solutions that meet the evolving needs of customers. As of October 2025, the competitive trends in the Legionella Testing Market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are becoming more prevalent, enabling companies to pool resources and expertise to address complex challenges. Looking ahead, competitive differentiation is expected to evolve, shifting from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition underscores the importance of agility and responsiveness in a market that is becoming ever more interconnected and complex.

## Recent News & Developments

- **Q2 2024: IDEXX Launches Legiolert Test for Rapid Detection of Legionella pneumophila in Water** IDEXX announced the launch of its Legiolert test, designed to rapidly detect Legionella pneumophila in water samples, aiming to improve public health safety and compliance with water testing regulations.
- **Q1 2024: QuidelOrtho Corporation Receives CE Mark for Sofia Legionella FIA Test** QuidelOrtho Corporation received CE Mark approval for its Sofia Legionella FIA test, enabling the company to market the product in the European Union for rapid detection of Legionella antigens in clinical samples.
- **Q2 2024: Thermo Fisher Scientific Expands Legionella Testing Market Portfolio with New PCR Assay** Thermo Fisher Scientific announced the expansion of its Legionella testing portfolio by launching a new PCR assay, designed to provide faster and more accurate detection of Legionella species in water systems.
- **Q2 2024: Bio-Rad Laboratories Announces Partnership with European Water Utility for Legionella Monitoring** Bio-Rad Laboratories entered into a partnership with a major European water utility to supply Legionella testing kits and support ongoing monitoring programs to prevent outbreaks in municipal water systems.
- **Q1 2024: Qiagen Launches New Automated Legionella Testing Market Platform** Qiagen launched a new automated platform for Legionella testing, aiming to streamline laboratory workflows and improve the speed and reliability of Legionella detection in environmental samples.
- **Q2 2024: Eiken Chemical Co., Ltd. Announces Expansion of Legionella Test Production Facility in Japan** Eiken Chemical Co., Ltd. announced the opening of an expanded production facility in Japan dedicated to manufacturing Legionella test kits, responding to increased demand for water safety testing.
- **Q1 2025: Pro-Lab Diagnostics Receives UK Regulatory Approval for New Legionella Rapid Test** Pro-Lab Diagnostics received regulatory approval in the UK for its new rapid Legionella test, allowing the company to market the product to healthcare and [environmental testing](https://www.marketresearchfuture.com/reports/environmental-testing-market-11269) laboratories.
- **Q2 2025:**Abbott Laboratories Launches Next-Generation Legionella Detection System Abbott Laboratories launched a next-generation Legionella detection system, featuring enhanced sensitivity and faster turnaround times for water testing in commercial and healthcare settings. The aim of the firm to reduce legionella testing cost is likely to bolster its position in the market.
- **Q1 2025: QuidelOrtho Corporation Announces Strategic Partnership with US Hospital Network for Legionella Surveillance** QuidelOrtho Corporation announced a strategic partnership with a large US hospital network to implement Legionella surveillance programs using its diagnostic products.
- **Q2 2024: Thermo Fisher Scientific Acquires Small Diagnostics Firm Specializing in Legionella Testing Market** Thermo Fisher Scientific completed the acquisition of a diagnostics firm specializing in Legionella testing, aiming to strengthen its position in the waterborne pathogen detection market.
- **Q1 2024: IDEXX Receives US EPA Approval for Legiolert Test Method** IDEXX received approval from the US Environmental Protection Agency (EPA) for its Legiolert test method, allowing its use in official water quality monitoring programs.
- **Q2 2025: Bio-Rad Laboratories Announces $20 Million Investment to Expand Legionella R&D** Bio-Rad Laboratories announced a $20 million investment to expand research and development efforts focused on new Legionella detection technologies and products.

## Report Scope

| MARKET SIZE 2024 | 0.83(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 0.8743(USD Billion) |
| MARKET SIZE 2035 | 1.471(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.34% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Thermo Fisher Scientific (US), Merck KGaA (DE), Hach Company (US), Eurofins Scientific (LU), SGS SA (CH), Bureau Veritas (FR), Intertek Group plc (GB), Pace Analytical Services, LLC (US), ALS Limited (AU) |
| Segments Covered | Test Type, Technology, Sample Type, End Users, Regional |
| Key Market Opportunities | Advancements in rapid testing technologies enhance detection capabilities in the Legionella Testing Market. |
| Key Market Dynamics | Rising regulatory scrutiny and technological advancements drive demand for efficient Legionella testing solutions across various sectors. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the current valuation of the Legionella Testing Market as of 2024?**
A: The Legionella Testing Market was valued at 0.83 USD Billion in 2024.

**Q: What is the projected market size for the Legionella Testing Market in 2035?**
A: The market is projected to reach 1.471 USD Billion by 2035.

**Q: What is the expected CAGR for the Legionella Testing Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the Legionella Testing Market during 2025 - 2035 is 5.34%.

**Q: Which test types are included in the Legionella Testing Market segments?**
A: The test types include Culture Tests, Polymerase Chain Reaction, Antigen Detection Tests, and Nucleic Acid Amplification Tests.

**Q: What are the projected valuations for Culture Tests and Polymerase Chain Reaction in 2035?**
A: Culture Tests are projected to reach between 0.45 and 0.65 USD Billion, while Polymerase Chain Reaction may reach between 0.35 and 0.55 USD Billion by 2035.

**Q: How do the different technologies in the Legionella Testing Market compare in terms of valuation?**
A: Molecular Methods are expected to have the highest valuation, projected between 0.35 and 0.65 USD Billion, compared to Traditional and Immunological Methods.

**Q: What types of samples are analyzed in the Legionella Testing Market?**
A: The market analyzes Water Samples, Environmental Samples, and Clinical Samples.

**Q: What is the projected valuation for Environmental Samples in 2035?**
A: Environmental Samples are projected to reach between 0.55 and 0.75 USD Billion by 2035.

**Q: Who are the key players in the Legionella Testing Market?**
A: Key players include Thermo Fisher Scientific, Merck KGaA, Hach Company, Eurofins Scientific, and SGS SA.

**Q: Which end users are driving demand in the Legionella Testing Market?**
A: End users include Hospitals, Laboratories, Public Health Organizations, and Research Institutions.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/legionella-testing-market-33014*